Evidence map›Paper›PMID 27231133›Full record

ReviewMicrobial biotechnology2016

Lactobacillus plantarum WCFS1 and its host interaction: a dozen years after the genome.

Maurits van den Nieuwboer, Saskia van Hemert, Eric Claassen, Willem M de Vos

Abstract readReview
In one paragraph

Review in Microbial biotechnology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Global Genomic Landscapes ofLife (Basel, Switzerland) · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Strategic antagonism: howFrontiers in microbiology · 2025
    Review
  11. Article
  12. Genomic Assessment of Potential ProbioticTropical life sciences research · 2024
    Article
  13. Article
  14. The role ofJournal of oral microbiology · 2024
    Review
  15. SynergisticMicrobiome research reports · 2024
    Review
  16. Engineered probioticMicrobiology spectrum · 2023
    Article
  17. Modulation of the Gut Microbiota by the Plantaricin-ProducingInternational journal of molecular sciences · 2023
    Article
  18. Antibiotics (Basel, Switzerland) · 2023
    Article
  19. Whole Genome Sequence ofJournal of microbiology and biotechnology · 2023
    Article
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Maurits van den NieuwboerAthena Institute, Vrije Universiteit, Amsterdam, The Netherlands.
Saskia van HemertWinclove BV Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0002-1098-1477
Eric ClaassenAthena Institute, Vrije Universiteit, Amsterdam, The Netherlands.
Willem M de VosLaboratory of Microbiology, Wageningen University, Wageningen, The Netherlands.

Funding

European Research Council 250172
6 · The paper itself

Abstract

Lactobacillus plantarum WCFS1 is one of the best studied Lactobacilli, notably as its genome was unravelled over 12 years ago. L. plantarum WCFS1 can be grown to high densities, is amenable to genetic transformation and highly robust with a relatively high survival rate during the gastrointestinal passage. In this review, we present and discuss the main insights provided by the functional genomics research on L. plantarum WCFS1 with specific attention for the molecular mechanisms related to its interaction with the human host and its potential to modify the immune system, and induce other health-related benefits. Whereas most insight has been gained in mouse and other model studies, only five human studies have been reported with L. plantarum WCFS1. Hence NCIMB 8826 (the parental strain of L. plantarum WCFS1) in human trials as to capitalize on the wealth of knowledge that is summarized here.

Indexed as

AnimalsClinical Trials as TopicDrug Evaluation, PreclinicalGastrointestinal TractHumansLactiplantibacillus plantarumMiceProbioticsTreatment Outcome

Identifiers

PMID27231133
PMCPMC4919987

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.